Ignite Creation Date:
2024-05-06 @ 3:02 PM
Last Modification Date:
2024-10-26 @ 1:41 PM
Study NCT ID:
NCT04502797
Status:
UNKNOWN
Last Update Posted:
2021-03-03
First Post:
2020-07-28
Brief Title:
A Feasibility Study to Evaluate The Effect of the Electronic Patient Visit Assessment On Pain and Quality of Life for Patients With Head and Neck Cancer HNC
Sponsor:
New York University
Organization:
New York University
Study Overview
Official Title:
A Feasibility Study to Evaluate The Effect of the Electronic Patient Visit Assessment On Pain and Quality of Life for Patients With Head and Neck Cancer HNC
Status:
UNKNOWN
Status Verified Date:
2021-03
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ePVA
Brief Summary:
This randomized non-blinded phase 0I study will assess the feasibility of conducting a large randomized clinical trial to evaluate the efficacy of the ePVA to improve pain management and HRQoL in HNC Thirty participants undergoing radiation therapy RT with or without chemotherapy will be randomized to 1 ePVA intervention or 2 usual care The intervention consists of participants completing the ePVA every other week during radiation therapy RT then weeks 4 12 and 24 after end of RT Automated reports of ePVA data including pain reports and patient-reports of pain medications will be sent to providers to inform their clinical decisions
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None